FeesSafety
Pluang+

L.B. Foster acquires Dulworth Enterprises to expand precast concrete and wastewater product offerings.

Company Fundamentals
29 Oct 2026, 15:00 WIB
GlobeNewsWire
View Source
Bullish
L.B. Foster acquires Dulworth Enterprises to expand precast concrete and wastewater product offerings.

L.B. Foster Company, through its subsidiary CXT Incorporated, acquired Dulworth Enterprises' operating assets for $52.2 million to enhance its precast concrete business and residential wastewater product portfolio. Dulworth, based in Texas, specializes in wastewater precast products and aerobic treatment systems, expected to add about $18 million in annual revenue and $6.5-$7.5 million EBITDA after integration. This acquisition supports L.B. Foster's growth strategy by expanding manufacturing capabilities and entering high-growth markets. Integration is expected to take 12 to 18 months.

L.B. Foster's acquisition of Dulworth Enterprises provides context for industrial sector activity. For readers following Industrials, here is Pluang's market snapshot as of Oct 29, 2026 17:53 WIB: out of 135 priced US industrial stocks, 76 rose and 57 fell. Notable movers include Bloom Energy at USD 218.20 with a 1-day change of -4.33%, AGCO Corporation at USD 98.00 with 100% buy order activity, and Flowserve Corporation at USD 74.51 with a 3.76% price increase.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App